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Abstract
Purpose
To evaluate the roles of known myopia-associated genetic variants for development of myo-
pic macular degeneration (MMD) in individuals with high myopia (HM), using case-control
studies from the Consortium of Refractive Error and Myopia (CREAM).
Methods
A candidate gene approach tested 50 myopia-associated loci for association with HM and
MMD, using meta-analyses of case-control studies comprising subjects of European and
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Asian ancestry aged 30 to 80 years from 10 studies. Fifty loci with the strongest associations
with myopia were chosen from a previous published GWAS study. Highly myopic (spherical
equivalent [SE]� -5.0 diopters [D]) cases with MMD (N = 348), and two sets of controls
were enrolled: (1) the first set included 16,275 emmetropes (SE� -0.5 D); and (2) second
set included 898 highly myopic subjects (SE� -5.0 D) without MMD. MMD was classified
based on the International photographic classification for pathologic myopia (META-PM).
Results
In the first analysis, comprising highly myopic cases with MMD (N = 348) versus emmetropic
controls without MMD (N = 16,275), two SNPs were significantly associated with high myo-
pia in adults with HM and MMD: (1) rs10824518 (P = 6.20E-07) in KCNMA1, which is highly
expressed in human retinal and scleral tissues; and (2) rs524952 (P = 2.32E-16) near
GJD2. In the second analysis, comprising highly myopic cases with MMD (N = 348) versus
highly myopic controls without MMD (N = 898), none of the SNPs studied reached Bonfer-
roni-corrected significance.
Conclusions
Of the 50 myopia-associated loci, we did not find any variant specifically associated with
MMD, but the KCNMA1 and GJD2 loci were significantly associated with HM in highly myo-
pic subjects with MMD, compared to emmetropes.
Introduction
Myopia is a refractive error condition that can usually be corrected with visual aids. It may
however result in significant complications, as high myopia (HM) increases the risk of myopic
macular degeneration (MMD). MMD, defined as the presence of myopia-specific retinal
pathology from excessive axial elongation, is characterized by structural degeneration of the
retina and associated with changes in the scleral wall [1]. MMD is one of the leading causes of
irreversible loss of vision and blindness worldwide [2–5]. Numerous genome-wide association
studies (GWAS) have identified multiple genetic variants associated with myopia or spherical
equivalent (SE) in the general population [6–12]. Several association studies [13–19] also sug-
gested overlapping genetic risk between myopia and HM that often correlate with blinding
complications [20]. Currently, only a relatively small number of loci have been associated with
HM [21–26].
Several single nucleotide polymorphisms (SNPs) associated with MMD have been identi-
fied in previous GWAS analyses in Japanese populations [27]. However, only one GWAS iden-
tified a locus specific to MMD at rs11873439 in CCDC102B, which compared high myopes
with MMD (cases) with high myopes without MMD (controls) [28]. In addition, some studies
had ambiguous definitions of MMD that did not refer to a single and formal classification sys-
tem, which limits comparability of findings [29, 30]. Therefore, genetic determinants of MMD
require validation using the recently established International META-PM classification system
for MMD [28].
For two of the most highly significant SNPs first associated with refractive error (GJD2 and
RASGRF1), no association with MMD was found in an ethnically-homogenous Chinese popu-
lation [31]. Further international studies with ethnically diverse populations are needed to
evaluate the roles of these variants in MMD.
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In this study, we evaluated the roles of known myopia-associated genetic variants in HM
and MMD, using case-control studies from the Consortium of Refractive Error and Myopia
(CREAM).
Methods
Study population and design
Subjects of either European or Asian ancestry, with available genome-wide genotyping and MMD
status information, from 10 different cohorts participating in the CREAM consortium (Table 1),
were included in this study [7, 15]. Subjects were between 30 and 80 years of age. A previous his-
tory of cataract surgery or laser refractive procedures that could alter refraction, were criteria for
exclusions from the analyses. A total of 17,521 subjects were included in this study.
The prevalence of MMD is higher in Asian cohorts, therefore most cases included in the
analyses were of Asian ancestry. The Singapore Epidemiology of Eye Diseases (SEED) studies,
consisting of the Singapore Chinese Eye Study (SCES), the Singapore Malay Eye Study
Table 1. Characteristics of cases (high myopes with myopic macular degeneration [MMD]) versus controls in first control set (emmetropes) and second control set
(high myopes without MMD).
Study, country Ethnicity Meta-PM
classifi-cation
Cases
(high myopes
with MMD)
[N = 348]
First control set
(emmetropes
without MMD)
[N = 16,275]
Second control set
(high myopes
without MMD)
[N = 898]
Total
[N = 17,521]
N Mean Age
(SD)
Mean SE
(SD)
N Mean Age
(SD)
Mean SE
(SD)
N Mean Age
(SD)
Mean SE
(SD)
Subjects of European
Ancestry
Blue Mountains Eye Study
(BMES), Australia
White
European
Yes 1,519 22 60.7 (6.8) -9.8 (3.2) 1,480 63.8 (7.6) 1.2 (1.3) 17 58.7 (7.3) -5.9 (1.1)
Rotterdam Study I (RS1),
Netherlands
White
European
Yes 4,340 46 70.1 (9.1) -6.9 (3.7) 4,165 66.7 (6.6) 2.5 (1.7) 129 67.9
(10.0)
-5.6 (2.4)
Rotterdam Study II (RS2) White
European
Yes 1,650 35 68.0 (8.4) -8.7 (3.3) 1,569 64.6 (7.4) 1.5 (1.5) 46 62.7 (5.1) -6.1 (1.8)
Rotterdam Study III (RS3) White
European
Yes 1,668 25 56.3 (4.1) -8.1 (3.9) 1,533 62.3 (5.6) 1.0 (1.4) 110 59.2 (5.4) -7.1 (1.6)
Gutenberg Health Study
(GHS) 1, Germany
White
European
Yes 919 7 55.3
(10.7)
-13.6
(3.3)
848 52.7
(10.1)
0.0 (0.3) 64 52.0
(10.2)
-8.0 (2.6)
GHS2 White
European
Yes 403 2 62.5
(10.7)
-8.5 (1.2) 366 52.4
(10.6)
0.0 (0.3) 35 47.8 (8.4) -8.0 (1.6)
Subtotal for Subjects of
European Ancestry
10,499 137 64.7 (8.0) -8.4 (3.5) 9,961 63.5 (7.3) 1.6 (1.5) 401 60.2 (8.3) -6.7 (2.1)
Subjects of Asian
Ancestry
Singapore Chinese Eye
Study (SCES), Singapore
Chinese Yes 1,529 38 58.1 (8.5) -10.0
(3.6)
1,357 58.9 (8.9) 0.8 (1.0) 134 51.9 (5.8) -6.9 (1.7)
Singapore Malay Eye Study
(SiMES), Singapore
Malay Yes 1,849 26 61.5
(11.5)
-8.8 (3.6) 1,779 58.7
(10.2)
0.7 (1.0) 44 50.4 (8.3) -7.4 (2.3)
Singapore Indian Eye
Study (SINDI), Singapore
Indian Yes 1,725 17 57.6 (8.2) -8.6 (3.3) 1,641 56.7 (8.8) 0.9 (1.1) 67 51.7 (6.8) -6.9 (1.7)
Nagahama cohort study,
Japan
Japanese Yes 1,919 130 52.1
(12.0)
-8.6 (3.0) 1,537 57.2
(12.2)
0.6 (1.0) 252 43.1
(10.5)
-7.2 (1.6)
Subtotal for Subjects of
Asian Ancestry
7,022 211 54.8
(11.1)
-8.9 (3.2) 6,314 57.9
(10.1)
0.7 (1.0) 497 47.3 (8.8) -7.1 (1.7)
Abbreviations: MMD, myopic macular degeneration; SE, spherical equivalent; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0220143.t001
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(SiMES) and the Singapore Indian Eye Study (SINDI), contributed a total of 81 cases, 4,777
controls (set 1), and 245 controls (set 2) [32, 33]. Another study consisting of individuals of
Asian ancestry, namely the Nagahama Study, contributed 130 cases, 1,537 controls (set 1), and
252 controls (set 2). The Rotterdam Studies (RS), comprising the RS1, RS2 and RS3 cohorts,
contributed 106 cases, 7,267 controls (set 1), and 285 controls (set 2) [34–38]. Other studies
with subjects of European ancestry contributed 22 cases, 1,480 controls (set 1) and 17 controls
(set 2) from the Blue Mountains Eye Study (BMES); and a total of 9 cases, 1,214 controls (set
1) and 99 controls (set 2) from the Gutenberg Health Study (GHS) 1 and GHS2 [39]. All stud-
ies were performed with the approval of their local medical ethics committee, and written
informed consent was obtained from all participants in accordance with the Declaration of
Helsinki. The names of the ethics committees of the individual studies are listed in the Sup-
porting Information (S2 Text).
Phenotypic assessment
Each subject underwent detailed ophthalmologic examination. Non-cycloplegic refraction sta-
tus was determined by the use of an autorefractor and/or subjective refraction. SE of refractive
error was defined as sphere plus half cylinder. Emmetropia and HM were defined as SE> -0.5
D and� -5.0 D in the right eye, respectively [40].
Fundus photograph grading was performed by trained graders for all HM subjects with
SE� -5.0 D in the right eye. The graders from each participating study underwent training by
experienced retinal specialist (K.O.M.), and all participating studies defined MMD based on
the International META-PM Photographic Classification and Grading System for MMD [28].
The presence of MMD was defined and classified into Meta-PM categories. MMD was graded
according to increasing severity: no macular lesions (category 0), tessellated fundus only (cate-
gory 1), diffuse chorioretinal atrophy (category 2), patchy chorioretinal atrophy (category 3),
and macular atrophy (category 4). Based on fundus photograph grading, the subject was con-
sidered to have MMD, if Meta-PM category 2, 3, or 4, was observed [1].
Evaluation of the role of myopia-associated genetic variants with MMD
We used a candidate gene approach that tested 50 genetic variants for association with MMD.
The 50 selected genetic variants were reported to be associated with myopia from the largest
GWAS study published to date [11]. Two case-control analyses were performed to evaluate the
roles of known myopia-associated genetic variants with the development of MMD in highly
myopic persons.
The first analysis aimed at identifying genetic variants associated with HM in highly myopic
subjects with MMD. It compared 348 highly myopic cases with MMD (SE� -5.0 D in the
right eye; mean SE range between -6.9 and -13.6 D) with 16,275 emmetropic controls without
HM or MMD (SE� -0.5 D in the right eye; mean SE range between 0.6 and 2.5 D). Of the 348
cases included, 137 (39.4%) and 211 (60.6%) cases were of European and Asian ancestries,
respectively. Of the 16,275 emmetropic controls, 9,961 (61.2%) and 6,314 (38.8%) were of
European and Asian ancestries, respectively.
The second analysis aimed at identifying genetic variants specifically associated with MMD.
We used the same group of cases (348 high myopes with MMD) and compared them with a
control set different from the previous one, that comprised 898 high myopes without signs of
MMD (mean SE range between -5.6 and -8.0 D). Of the 898 highly myopic controls, 401
(44.7%) and 497 (55.3%) were of European and Asian ancestries, respectively.
Genotyping and imputation were executed as previously described [41]. Stringent quality
control (QC) procedures of genotyping before imputation were applied in each study. Briefly,
Genetic variants linked to myopic macular degeneration in persons with high myopia
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duplicate DNA samples, subjects with low call rate (< 95%), gender mismatch, or ethnic
outliers were excluded. SNPs were excluded if they had a low genotyping call rate (> 5% miss-
ingness), a minor allele frequency (MAF) of less than 1%, or were Hardy-Weinberg disequilib-
rium (P< 10−6). After QC filtering, genomic imputation was performed using the 1000
Genomes Project data as reference panel (build 37, phase 1 release, March 2012) with Minimac
[42] or IMPUTE2 [43]. SNPs with MAF� 5% and imputation quality of at least 0.5 (r2 for
MACH or info score for IMPUTE) were included in further analyses.
Gene expression in human ocular tissues
Adult ocular samples were obtained from the normal eyes of an 82-year-old Caucasian female
from the North Carolina Eye Bank, Winston-Salem, North Carolina, USA. Fetal ocular sam-
ples were obtained from 24-week fetal eyes by Advanced Bioscience Resources Inc., Alameda,
California, USA. The adult ocular samples were stored in Qiagen RNA later within 6.5 hours
of collection and shipped on ice overnight to the lab. Fetal eyes were preserved in RNA later
within minutes of harvesting and shipped over night on ice. Whole globes were dissected on
the arrival day. Isolated tissues were snap-frozen and stored at −80˚C until RNA extraction.
RNA was extracted from each tissue sample independently using the Ambion mirVana total
RNA extraction kit. The tissue samples were homogenized in Ambion lysis buffer with an
Omni Bead Ruptor Tissue Homogenizer per protocol. Reverse transcription reactions were
performed with Invitrogen SuperScript III First-Strand Synthesis kit. The expression of the
identified genes was assessed by running 10 μl reactions with QIAGEN’s PCR products con-
sisting of 1.26 μl H2O, 1.0 μl 10× buffer, 1.0 μl dNTPs, 0.3 μl MgCl, 2.0 μl Q-Solution, 0.06 μl
taq polymerase, 1.0 μl forward primer, 1.0 μl reverse primer, and 1.5.0 μl cDNA. The reactions
were run on an Eppendorf Mastercycler Pro S thermocycler with touchdown PCR ramping
down 1˚C per cycle from 72˚C to 55˚C followed by 50 cycles of 94˚C for 30 s, 55˚C for 30 s,
and 72˚C for 30 s with a final elongation of 7 min at 72˚C. All primer sets were designed by
Primer3 [44]. Gel electrophoresis was run on a 2% agarose gel at 70 volts for 35 minutes. The
primers were run on a custom tissue panel including the Clontech Human MTC Panel I, Fetal
MTC Panel I, and an ocular tissue panel.
Statistical analysis
Logistic regression models were performed for all studies with each SNP as predictors, and
MMD as a binary outcome, with adjustments for age, gender, and principal components. To
avert population stratification and inflation of the results in each cohort, the ancestry of all par-
ticipants was checked via a Principal Component Analysis. Individuals who were not perfectly
clustering with their respective ethnic groups were removed. Meta-analyses were performed to
estimate the combined effects, using inverse-variance fixed-effect meta-analyses in METAL
[45]. The meta-analyses were stratified by ancestry (European or Asian ancestry). Only SNPs
that were available and polymorphic in at least 8 participating studies were considered. Of the
50 SNPs, 39 and 37 were included in the first analysis (highly myopic cases with MMD versus
emmetropic controls without MMD) and second analysis (highly myopic cases with MMD
versus highly myopic controls without MMD), respectively. Corrections for multiple testing
were performed: PBonferroni = 0.05/39 = 1.28E-03 for the first analysis and PBonferroni = 0.05/
37 = 1.35E-03 for the second analysis.
Results
The highly myopic cases with MMD (mean SE of -8.67 ± 3.3 D; N = 348) were more myopic
than the highly myopic controls without MMD (mean SE of -6.89 ± 1.89 D; N = 898). The
Genetic variants linked to myopic macular degeneration in persons with high myopia
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mean SE of the emmetropic controls without MMD was 1.43 ± 1.43 D (N = 16,275). Com-
pared to the subjects of European ancestry, subjects of Asian ancestry were more myopic in
the cases and two control groups (Table 1).
(1) Evaluation of genetic variants associated with HM in highly myopic
subjects with MMD
In the first analysis (highly myopic cases with MMD versus emmetropic controls without
MMD), two SNPs were significantly associated with HM in highly myopic subjects with MMD
(Table 2). rs10824518 (P = 6.20E-07; Fig 1A) maps within the KCNMA1 gene genomic
sequence and rs524952 (P = 2.32E-16; Fig 1B) about 38kbp downstream the GJD2 gene. A
third SNP, rs13380104 (P = 1.73E-03; Fig 1C), located in the last intron of the RASGRF1 gene,
was just short of our pre-defined Bonferroni corrected threshold of significance.
(2) Evaluation of genetic variants specifically associated with MMD
In the second analysis, (highly myopic cases with MMD versus highly myopic controls without
MMD), none of the SNPs reached Bonferroni-corrected significance in this model (Table 3).
The highest association was observed for rs479445 (P = 2.55E-02), located downstream of the
NFIA gene.
To assess whether the SNPs associated with myopia had any role in HM and MMD predis-
position, quantile-quantile plots of the P-values from each meta-analysis were examined (Fig
2). Associations of genetic variants for HM and MMD between highly myopic cases with
MMD and emmetropic controls without MMD showed significance, beyond what would be
expected under the assumption of a uniform distribution (Kolmogorov Smirnov for unifor-
mity p = 3.87E-05), as the test statistic distribution deviated from expectations for the first
analysis (Fig 2A). In contrast, after the influence of HM was removed in the second analysis,
Table 2. List of the 10 SNPs most significantly associated with HM in highly myopic subjects with myopic macular degeneration (MMD) from the meta-analysis in
first case-control study (cases [high myopes with MMD] versus first control set [emmetropes]).
SNP Gene Allele1 Allele2 Effect
size
Standard
Error
P-value I2
(heterogenity)
X2
(heterogenity)
Deg of
freedom
P-value
(heterogenity)
rs524952 GJD2 a T 0.4941 0.0602 2.32E-
16
3.8 10.396 10 0.4065
rs10824518 KCNMA1 a T 0.3691 0.0741 6.20E-
07
49.1 19.637 10 0.03288
rs13380104 RASGRF1 t C 0.2809 0.0897 1.73E-
03
0 3.922 10 0.9508
rs7162310 APH1B t C -0.227 0.0979 2.04E-
02
31.1 14.506 10 0.1511
rs2908972 SHISA6 a T 0.1843 0.0927 4.69E-
02
0 5.675 10 0.8418
rs11606250 LRRC4C a G 0.1913 0.1031 6.36E-
02
0 7.841 10 0.6444
rs4948523 BICC1 a C 0.1444 0.0814 7.60E-
02
0 8.966 10 0.5353
rs7968679 PZP a G -0.1423 0.12 2.36E-
01
0 9.033 10 0.529
rs1793639 NTM a G -0.0662 0.101 5.12E-
01
0 4.577 10 0.9176
rs11658305 POLR2A/ TNFSF12/
TNFSF13
a C -0.0196 0.0862 8.20E-
01
27.5 13.797 10 0.1825
https://doi.org/10.1371/journal.pone.0220143.t002
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the associations of genetic variants for MMD between highly myopic cases with MMD and
highly myopic controls without MMD were not significantly different from the null hypothesis
of a uniform distribution (p = 0.64) (Fig 2B).
The effect sizes of the genetic variants reported for myopia were strongly correlated with
the effect sizes of the SNPs in the first analysis (Fig 3A), reflecting the correlation (Spearman’s
ρ = 0.70, p = 1.15E-07) of myopia with HM and MMD. Several genetic loci (such as KCNMA1
and GJD2) displayed stronger effects over HM and MMD than SE. Alternatively, for some
Fig 1. Plot of the effect on high myopia in highly myopic subjects with myopic macular degeneration for (A)
rs10824518, (B) rs524952, and (C) rs13380104 in the population cohorts in first case-control study. For each
cohort, the circle shows the β linear regression coefficient and the bars represent the standard error for the estimate.
BMES, the Blue Mountains Eye Study, Australia; RS-I, the first Rotterdam Study cohort, Netherlands; RS-II, the
second Rotterdam Study cohort, Netherlands; RS-III, the third Rotterdam Study cohort, Netherlands; GHS1, the first
Gutenberg Health Study cohort, Germany; GHS2, the second Gutenberg Health Study cohort, Germany; SCES, the
Singapore Chinese Eye Study, Singapore; SiMES, the Singapore Malay Eye Study, Singapore; SINDI, the Singapore
Indian Eye Study, Singapore; Nagahama, the Nagahama Study cohort, Japan.
https://doi.org/10.1371/journal.pone.0220143.g001
Table 3. List of the 10 SNPs most significantly associated with myopic macular degeneration (MMD) exclusively from the meta-analysis in second case-control
study (cases [high myopes with MMD] versus second control set [high myopes without MMD]).
SNP Gene Allele1 Allele2 Effect
size
Standard
Error
P-value I2 (heterogenity) X2
(heterogenity)
Deg of
freedom
P-value
(heterogenity)
rs479445 C1orf87 /NFIA a T 0.2955 0.1323 2.55E-
02
0 7.97 10 0.6317
rs2207136 TFAP2B t C 0.2508 0.1346 6.24E-
02
0 9.133 10 0.52
rs13380104 RASGRF1 t C 0.1564 0.1304 2.30E-
01
0 5.808 10 0.8312
rs7744813 KCNQ5 a C -0.154 0.1391 2.68E-
01
0 5.486 10 0.8564
rs2808510 NR5A2 /ZNF281 t C 0.129 0.1281 3.14E-
01
30 14.276 10 0.1608
rs11606250 LRRC4C a G 0.1198 0.1514 4.29E-
01
0 5.223 10 0.8758
rs2799081 PGBD1
/ZSCAN31
t C 0.1036 0.1374 4.51E-
01
0 4.2 10 0.9379
rs2155413 DLG2 a C -0.0664 0.1276 6.03E-
01
13.9 11.614 10 0.3117
rs10824518 KCNMA1 a T -0.0727 0.1486 6.25E-
01
0 4.519 10 0.9209
rs4948523 BICC1 a C 0.0416 0.1239 7.37E-
01
0 4.918 10 0.8966
https://doi.org/10.1371/journal.pone.0220143.t003
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other loci previously associated with myopia [11], we observed weaker or no effect at all over
HM and MMD (for example DLG and COL61A). There was a marginally weaker correlation
of the effect sizes between the first and second case-control analysis (Spearman’s ρ = 0.59,
p = 0.0001, Fig 3B), perhaps reflecting an overlap of genetic risks between HM and MMD.
Gene expression in human ocular tissues
As the expression and role of GJD2 and RASGRF1 in eye and myopia development have been
explored and reported previously [6–9, 15], we focused on the gene expression of KCNMA1 in
human ocular tissues. KCNMA1 was expressed in most adult and fetal ocular tissues, including
human retina, sclera, choroid or retinal pigment epithelium (RPE), and optic nerve (Table 4).
In particular, KCNMA1 was highly expressed in human retina and sclera for both fetal and
adult tissues.
Discussion
Using two case-control meta-analyses, this study evaluated genetic risk factors for the develop-
ment of MMD in adults with HM who have MMD. We found that KCNMA1 is linked to HM
in highly myopic individuals with MMD in CREAM, a locus that had been previously identi-
fied for myopia in CREAM and 23andMe [12]. Furthermore, we replicated previously reported
association on GJD2 and RASGRF1 in highly myopic individuals with MMD compared to
emmetropic controls without MMD. However, these results were not replicated in the second
case-control study that compared highly myopic cases with MMD and highly myopic controls
without MMD. Since these genetic variants were not tested positive in both case-control
Fig 2. Quantile-quantile plots for the meta-analyses in first and second case-control studies. (A) Q-Q plot for association between analysed SNPs and HM in high
myopes with MMD in first case-control study (highly myopic cases with MMD versus emmetropic controls without MMD); (B) Q-Q plot for association between analysed
SNPs and MMD specifically in second case-control study (highly myopic cases with MMD versus highly myopic controls without MMD). Each dot represents an observed
statistic (defined as–log10p) versus the corresponding expected statistic. The red line corresponds to the null distribution. The shaded areas represent the 95% confidence
intervals.
https://doi.org/10.1371/journal.pone.0220143.g002
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studies, we found no evidence that any of the variants that we analysed, confers risk specific to
MMD, beyond risk mediated through HM. These genes might be linked to development of
MMD only in these highly myopic subjects with MMD.
Fig 3. Association plots of effect sizes for the meta-analyses in first and second case-control studies. (A) Relation of effect sizes observed in original study for myopia
(Pickrell et al 2016) versus that in the first case-control study (highly myopic cases with MMD versus emmetropic controls without MMD) for HM in high myopes with
MMD; (B) Relation of effect sizes in first case-control study (highly myopic cases with MMD versus emmetropic controls without MMD) for development of MMD in
those with HM versus that in the second case-control study (highly myopic cases with MMD versus highly myopic controls without MMD) for MMD specifically.
https://doi.org/10.1371/journal.pone.0220143.g003
Table 4. Expression of KCNMA1 in the various human eye tissues.
KCNMA1
Tissue Expression p-value
Retina Adult Retina 890.32 <0.001
Adult Peripheral Retina 551.12 <0.001
24 week Retina/RPE 560.04 <0.001
24 week Peripheral Retina/RPE 366.33 <0.001
12 week Retina/ RPE/Choroid 52.91 0.10
Sclera Adult Sclera 1013.48 <0.001
Adult Peripheral Sclera 743.71 0.14
24 week Sclera 317.22 <0.001
24 week Peripheral Sclera 434.30 <0.001
12 week Sclera 124.44 <0.001
Choroid
/RPE
Adult Choroid 152.77 <0.001
Adult Peripheral Choroid 179.41 <0.001
24 week Choroid 218.18 <0.001
24 week Peripheral Choroid 257.90 <0.001
Optic nerve Adult Optic nerve 549.38 <0.001
Fetal Optic nerve 162.67 <0.001
Abbreviations: RPE, retinal pigment epithelium.
https://doi.org/10.1371/journal.pone.0220143.t004
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Several genetic variants associated with MMD have been reported in the literature [29, 30],
but few have been consistently replicated [31]. A previous GWAS identified a genetic locus
associated with MMD at rs11873439 in CCDC102B (N = 7739; P = 1.61E-10; odds ratio [OR]
of 1.46; 95% confidence interval [CI], 1.30 to 1.64). The CCDC102B gene protein may be
linked to weakened connective tissue in retinal and choroid layers, which predisposes the eye
to MMD [27]. Another GWAS analysis (N = 2,741) found an association between rs577948 in
BLID (OR of 1.37; 95% CI, 1.21 to 1.54; P = 2.22E-07) [29], which encodes an inducer of mito-
chondrial cell death and apoptosis and expressed in human retina [46]. We did not find similar
results to previous studies, as this could potentially be due to small sample size or the greater
complexity of MMD that may have multifactorial, polygenic and environmental influences.
We have confirmed at least the KCNMA1 locus (10q22) as a susceptibility locus for HM in
persons with both HM and MMD. KCNMA1 was identified as a susceptibility locus for SE and
myopia in the wider general population in two previous large GWAS [6, 11, 12], but we
observed much stronger effects and association near the high myopic end of the refraction
spectrum. Encoding a large potassium voltage-sensitive conductance calcium-activated chan-
nel (MaxiK+) [47], KCNMA1 is mainly involved in ion channel activity [48], control of smooth
muscle and neuronal development [49], action potential repolarization of neurons [50], regu-
lation of neurotransmitter release [51] and synaptic plasticity [47]. Notably, MaxiK+ channels
control synaptic transmission exclusively in the rod pathway, a light-induced signalling path-
way that contributes to myopia development [52]. KCNMA1 is expressed in neurons, retinal,
and RPE tissues [47, 51, 53]. MaxiK+ channels in RPE control the changes in intracellular Ca2
+, in turn regulating several cell functions including dark adaptation of photoreceptor activity,
differentiation and vascular endothelial growth factor (VEGF) secretion [54, 55], thereby sug-
gesting possible involvement of KCNMA1 in myopia-related pathologic changes, such as the
initiation of choroidal neovascularization and changes in the blood-retinal barrier [56]. Vali-
dation of the role of KCNMA1 in myopia progression is needed, particularly in ion channel
activity which is one of the major functional pathways implicated, with an existing pool of sev-
eral associated genes (KCNQ5, KCNJ2, and CACNA1D) [7].
As the first two susceptibility loci found to be associated with myopia [6, 8, 9, 12, 18, 57,
58], GJD2 [59, 60] and RASGRF1 [13, 17, 61] were significantly associated with HM in those
with HM and MMD in the current study and previous studies. However, similar to previous
work, GJD2 [31] and RASGRF1 [17, 31] were not specifically associated with MMD. GJD2
[62–65] plays an essential role in synaptic transmission and processing of visual signals in pho-
toreceptors and retinal cells [64, 66–69], and seems to be controlled by light exposure and
dopamine [70], both of which have established roles in eye growth and myopia development
[57, 71, 72]. RASGRF1 [66, 68, 73] is involved in neuronal signal transduction pathways for ret-
inal maintenance and function, and synaptic transmission of the photoreceptor responses
[68]. Downregulated RASGRF1 expression in mice models have resulted in impaired memory
consolidation and learning [74], and deficiencies in photoreception and visual sensory pro-
cesses [68].
We acknowledge that there may be limitations to our study. Our study is likely to be under-
powered to detect associations between the candidate genetic variants and HM and MMD,
due to the small sample size of MMD cases. The direction of effect in our study were similar to
that in the previously reported GWAS for KCNMA1 and GJD2,[11] thus indicating the lack of
sufficient power in this study. As the prevalence of MMD in the population is low at 1–3% [2],
it is logistically difficult to collect a sufficient number of cases with both MMD and genotyping
information. It is unclear if the genetic variants reported in our findings are associated with
HM, as the control group used in the first analysis should ideally be low and moderate myopes
without MMD, instead of emmetropes without MMD. Therefore, these genetic variants are
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associated with HM in a specific population of those with both MMD and HM. We do not have
individual data from each participating study on other factors that might be associated with
MMD, for instance myopia duration. Although our study population has ethnic diversity, com-
prising individuals of European and Asian ancestries, the nonsignificant associations may be
due to genetic heterogeneity across populations of varying ethnicity. It may be due to the multi-
factorial influences on this complex ocular disease as well. In addition, due to the nature of our
candidate study, we focused on SNPs with strong prior evidence of association with myopia. In
that respect, it may be unsurprising that these loci did not confer any significant effect over
MMD, independent of their effect over HM. We did not conduct a GWAS and this study evalu-
ated only the top SNPs for myopia, thus genetic variants that specifically affect MMD but have
weak or no associations with myopia were not examined in this study. As only the top SNPs
with stronger association with myopia were tested, we may have missed significant associations
of untested SNPs with weaker associations with myopia present in the same locus as the top
SNPs that were tested. Further verification and replication of our findings are required.
Conclusions
In our study, we did not find any myopia-associated variant that was specifically associated
with MMD. However, we report a significant association between HM in highly myopic sub-
jects with MMD and the rs10824518 SNP in the KCNMA1 locus in an international and multi-
ethnic study. We also replicated and verified associations between HM in highly myopic sub-
jects with MMD and the first gene associated with SE (GJD2). Further studies of larger sample
sizes are required to elucidate susceptibility loci exclusive to MMD.
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